# Boehringer Ingelheim to build €200M veterinary vaccine plant in Lyon, France

Boehringer Ingelheim will invest more than €200 million to establish a new strategic production center for Veterinary Public Health in Lyon, France. The facility will produce foot-and-mouth disease and Bluetongue virus vaccines, creating approximately 100 jobs, and is expected to be operational by the end of 2021.

- Type: New facility
- Announced: 2018-07-10
- Where: Lyon, Rhône-Alpes region, France
- Value: $234.0M (200.0M EUR)
- Jobs: 100
- Starts operating: 2021
- Status: announced
- Capacity: 15,000 square metres high-technology building
- Products: foot-and-mouth disease vaccine, Bluetongue virus vaccine
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [biospace.com](https://www.biospace.com/boehringer-ingelheim-invests-more-than-200-million-to-establish-strategic-production-center-for-veterinary-public-health-in-france), 2018-07-10: "This is a record investment into our production network."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.